A considerable number of diagnostic tests are available or in development for the detection of autoimmune diseases. Because of this potentially large and growing market, vast opportunity exists for discovery and advancement in this arena.
Competition within this market is expected to increase dramatically. However, in fledgling autoimmune IVD diagnostic testing markets, a golden opportunity exists to capitalize on new testing innovations without significant competition.
In terms of test options, a substantial amount of overlap exists in the various autoimmune tests available. With the continued medical discovery of autoimmune conditions, the research and development of accurate tests to identify specific diseases provide the potential revenue opportunities that may exist for future tests and competitors.
Scope and Methodology
Autoimmune Immunoassay Brief offers a geographic scope that is worldwide with information for specific geographical regions, world autoimmune demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by region and test segment. Additionally, key company profiles are included. The market does not include services for autoimmune immunoassay testing.
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information.
For the purpose of this study, the publishing team conducted interviews with over 12 industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers' level. The market includes manufacturer tests excluding services. The base year for data was 2021. Compound annual growth rates (CAGRs) are provided for 2021-2026 periods. The forecasted market analysis for 2021-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.
Key Topics Covered:
Chapter 1: Executive Summary
Scope And Methodology
Size And Growth Of The Market
Key Issues And Trends Affecting The Market
Conclusion 1: There Are Vast Opportunities For Manufacturers Of Autoimmune Diagnostic Testing
Products In The Autoimmune Arena
Conclusion 2: Women Are Disproportionately Affected By Autoimmune Disease
Conclusion 3: Testing Needs To Be Cost Effective But Precise To Identify Autoimmune Diseases
Conclusion 4: Sophistication In Testing Is Leading To More Automated Effective Testing
Conclusion 5: Proteonomic Research Is Furthering The Discovery Of Autoimmune Disease Markers
Chapter 2: Introduction and Overview
Types Of Autoimmune Diseases
Autoimmune Gastrointestinal Disease
Inflammatory Bowel Disease
Systemic Lupus Erythematosus
Autoimmune Thyroid Disease
Type 1 Diabetes
Types Of Tests
Enzyme-Linked Immunosorbent Assay
Ifa/ Anti-Neutrophil Cytoplasmic Antibodies (Anca)
Prevalence And Demographics Of Autoimmune Disease
Prevalence In Women
Chapter 3: Emerging Trends
Patient Engagement/Patient-Centered Healthcare
Automated Autoimmune Diagnostic Platforms
Cell And Gene Therapy Opportunities
Chapter 4: Market Participants
Aesku. Diagnostics Gmbh & Co Kg
Aesku Corporate Summary
Binding Site Group Ltd. (The)
Bio-Rad Laboratories Inc.
Hob Biotech Group
Inova Diagnostics, Inc.
Roche Diagnostic Corporation
Siemens Healthineers Gmbh
Thermo Fisher Scientific
Trinity Biotech Plc
Chapter 5: Market Analysis
Market By Region
Autoimmune Immunoassay Testing Market By Region
Market By Segment
Autoimmune Immunoassay Market By Disease Type
For more information about this report visit https://www.researchandmarkets.com/r/ou1cgi
View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005968/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900